Advertisement

iPSC-derived natural killer cells expressing the Fc{gamma}R fusion CD64/16A can be armed with antibodies for multitumor antigen targeting

January, 01, 2024 | Select Oncology Journal Articles

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –

Advertisement

LATEST

Advertisement

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy